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Taxol is a potent anti-mitotic drug used in chemotherapy, angioplastic stents, and cell biology research. By binding and
stabilizing microtubules, Taxol inhibits their dynamics, crucial for cell division, motility, and survival. The drug has also been
reported to induce formation of asters and bundles composed of stabilized microtubules. Surprisingly, at commonly used
concentrations, Taxol forms crystals that rapidly bind fluorescent tubulin subunits, generating structures with an uncanny
resemblance to microtubule asters and bundles. Kinetic and topological considerations suggest that tubulin subunits, rather
than microtubules, bind the crystals. This sequestration of tubulin from the subunit pool would be expected to shift the
equilibrium of free to polymerized tubulin to disfavor assembly. Our results imply that some previously reported Taxol-
induced asters or bundles could include or be composed of tubulin-decorated Taxol crystals. Thus, reevaluation of certain
morphological, chemical, and physical properties of Taxol-treated microtubules may be necessary. Moreover, our findings
suggest a novel mechanism for chemotherapy-induced cytotoxicity in non-dividing cells, with far-reaching medical
implications.
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INTRODUCTION
In 1971, Taxol (paclitaxel) was isolated from the Pacific yew tree,
Taxus brevifolia, and shown experimentally to have antitumor
activity [1]. Through work in the laboratory of S. B. Horwitz,
Taxol’s novel mechanism of action was discovered: it binds to and
stabilizes microtubules, inhibiting progression through the cell
cycle [2]. More specifically, Taxol stabilizes microtubules [3] by
binding stoichiometrically (or substoichiometrically [4]) within
their lumen [5]. The consequent loss of microtubule dynamics is
thought to impair the mitotic spindle, thus causing cell cycle arrest
at the metaphase-to-anaphase transition, and ultimately, cell death
by apoptosis [2], [6].
Taxol has been used extensively as an antitumor drug (reviewed
in [7]), and more recently in drug eluting stents to prevent
reblockage of coronary arteries after balloon angioplasty (reviewed
in [8]). In addition to its medical applications, Taxol is frequently
used in research for studying microtubules and microtubule-based
structures, such as cilia, flagella, spindles, asters, and bundles. It
has also been widely reported to induce extensive polymerization
of microtubules, and their assembly into bundles and/or asters
(e.g., [4], [9–15]), particularly at higher concentrations.
In this study we have documented an unexpected property of
the drug that could necessitate a reinterpretation of many
microtubule-based studies, and that has the potential for major
medical implications. Specifically, Taxol forms crystals that
superficially resemble microtubules, and that sequester the tubulin
building blocks of microtubules. In other words, crystallized Taxol
bound by free tubulin can masquerade as polymerized tubulin
bound by free Taxol.
RESULTS AND DISCUSSION
Taxol is known to function by binding the inner surface of
microtubules and stabilizing them in their polymerized state [2],
[5]. Thus, we expected to observe only individual microtubules in
a commonly used microtubule assembly buffer containing
fluorescently labeled tubulin and 20 mM Taxol (as in Materials
and methods). Unexpectedly, asters and bundles were also
observed (Fig. 1 A), despite the absence of cellular constituents
thought to be required for their formation (e.g., [16–18]). These
structures could be seen both by fluorescence and differential
interference contrast (DIC) microscopy. More surprisingly, asters
and bundles were also present in an otherwise identical control
solution lacking tubulin, and could be visualized only by DIC
microscopy (Figs. 1 B, 3 B).
Given the low solubility of Taxol inaqueous solutions [19], and its
tendencytoformneedle-likedihydratecrystals[20],wededucedthat
we were seeing Taxol crystals. Apparently, the crystalline needles
had self-assembled into bundles and asters that closely resembled the
Taxol-stabilized microtubule structures reported in many studies
(e.g., [9], [21]). Assembly could have occurred by some combination
of collision of needles in solution, lateral nucleation on preexisting
needles, or nucleation of multiple needles on a single impurity (speck
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fluorescent tubulin subunits, allowing the decorated crystals to
masquerade as stabilized microtubule structures (Fig. 1 A).
To test our hypothesis, we prepared Taxol crystals, and exposed
them to fluorescently labeled tubulin as follows. Stock Taxol in
solvent wasdiluted inbufferto 20 mM,creatingcrystalline asters and
bundles. The crystals were pipetted under oil onto a chamber slide.
Ice-cold, fluorescently labeled tubulin subunits were micropipetted
into the chamber, to one side of the crystals, allowing us to visualize
their trajectory in real time using fluorescence microscopy. The
crystals began to fluoresce almost instantly (Fig. 2 A), consistent with
rapid binding of tubulin to the crystal rather than the slower
assembly of microtubules on the crystal surface. In a separate
experiment, tubulin was allowed to assemble into microtubules and
the equilibrium solution of microtubules and tubulin subunits was
pipetted near the crystal. Once again, the crystals were labeled
almost instantly by the subunits, whereas the slower-moving
microtubules were observed to diffuse past the crystal (Fig. 2 B).
Both experiments suggested that crystals were decorated by free
tubulin rather than by microtubules. Furthermore, since free Taxol
binds the inner surface of microtubules, it would be topologically
impossible for intact microtubules to bind the crystal via the
previously characterized Taxol-binding site [5].
The formation oftubulin-decorated crystal asters and bundles was
dependent on Taxol concentration (Fig. 3 A). Asters were not
observed when microtubules were stabilized with concentrations
below ,0.9 mM. At Taxol concentrations above ,0.9 mM, asters
formed in 15 minutes or less (Fig. 3 A). Crystallization occurred
progressively faster as the concentration increased. Asters formed
even during preparation of 1–20 mM Taxol, if dilutions from stock
Taxol were not made quickly and mixed thoroughly. Furthermore,
longer incubations of saturated Taxol solutions (compare Fig. 1 B to
Fig. 3 B), as well as higher concentrations of Taxol (compare Fig. 3
A, 1 mMv s2 0mM Taxol), produced asters and bundles with longer
needles.
Taxol has often been used under conditions in which
crystallization is certain or likely to occur (based on issues raised
in [19], [22]). There is an incongruity between the low solubility of
Taxol in aqueous solution and the considerably higher concen-
trations at which the drug is often used. Taxol is soluble in
Dimethyl sulfoxide solvent, but upon dilution into aqueous
solutions at concentrations greater than 0.77 mM (0.66 mg/mL),
it eventually precipitates [19]. Thus, conclusions based on studies
using concentrations in the micromolar range may be subject to
misinterpretation. Even at low nanomolar concentrations in the
extracellular medium, Taxol can be concentrated by cultured cells,
which can readily attain intracellular saturation (i.e., [Tax-
ol].0.77 mM) [22]. Rate of uptake differs from one cell line to
the next and must be determined experimentally [23]. Signifi-
cantly, intracellular Taxol concentrations are rarely measured.
Our results imply that some previously reported Taxol-induced
asters or bundles could either include or be composed of tubulin-
decorated Taxol crystals, and could easily be mistaken for Taxol-
stabilized microtubules. Similarly, a single decorated crystalline
needle could resemble an individual stabilized microtubule. Thus, it
would be prudent to reevaluate morphological, chemical, and
physical properties of Taxol-treated microtubules, such as sedimen-
tation, turbidity, rigidity, birefringence, affinity, stability, and
thermodynamics of assembly. Of course, we do not mean to suggest
that all or most previous work on Taxol is suspect or invalid. We are
merely stating that in certain cases, particularly those involving high
concentrations of Taxol, or those resulting in unexpected or
contradictory conclusions, it is worth considering an alternative
explanation.
For example, VanBuren et al. summarize published values for
flexural rigidity of the microtubule, as measured by various
Figure 1. Taxol crystals resemble asters and bundles formed in the presence of Taxol-stabilized microtubules. (A) Two asters (top and middle)
and one bundle (bottom) formed in the presence of Taxol and fluorescently labeled tubulin, as in text. Paired images with DIC (left) and fluorescent
(right) optics. (B) DIC images of a Taxol crystal aster (top) and bundle (bottom), formed in the absence of tubulin. Bars, 10 mm.
doi:10.1371/journal.pone.0001476.g001
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astounding range of values. We hypothesize that some disagree-
ment may stem from the inadvertent use of tubulin-decorated
Taxol crystals in studies in which microtubules were stabilized
with saturated concentrations of Taxol.
In addition, our data are inconsistent with reports that high
concentrations of Taxol can induce polymerization of massive
quantities of microtubules, in vivo or in vitro (see, for example, [9],
[4]). Our results imply that Taxol crystals would sequester tubulin
from the subunitpool, shifting the equilibrium of free to polymerized
tubulin in a direction disfavoring assembly. Taxol-induced polymer
contentincells hasbeen measured byisolating cytoskeletons inorder
to separate microtubules from free tubulin. However, because
tubulin-decorated Taxol crystals would be expected to co-sediment
withthe cytoskeleton,centrifugation-basedassayscould overestimate
the amount of microtubule-stabilized polymer by disregarding the
presence of decorated crystals. Turbidity-based assays could result in
similar overestimates.
In contrast, very low, subsaturated concentrations of Taxol
would indeed be expected to induce additional polymerization by
stabilizing existing microtubules, shifting the equilibrium toward
polymerization. This was demonstrated by the study of Derry et
Figure 2. Taxol crystals bind fluorescently labeled tubulin subunits. (A) Fluorescently labeled tubulin (released from a micropipette to the left of
the field) immediately accumulated on the preformed Taxol crystal aster, as shown in these sequential images. (B) An equilibrium solution of
fluorescently labeled tubulin (green haze) and microtubules was released as in (A), and decorated a Taxol ‘bow-tie’ (i.e., nonspherical) crystal aster
(half of aster is visible, in upper right). Again, the crystal was instantly labeled by subunits, which diffuse more rapidly than microtubules.
Microtubules did not appear to contribute to the brightness of the tubulin-decorated crystal, as fluorescence intensity did not increase over time.
Thus, microtubules did not appear to play a major role in decorating the Taxol crystal. The arrow tracks the path of a single microtubule that briefly
made contact with the aster, but diffused away. The shallow aqueous puddle containing the crystal aster is outlined in the first panel. Time in
seconds. Bars, 10 mm.
doi:10.1371/journal.pone.0001476.g002
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concentrations of Taxol on the mass of microtubule polymer [4].
The mass was reported to increase in a biphasic manner, with an
increase over controls for 10–50 nM Taxol (by polymerization), no
significant increase between 50 and 500 nM Taxol, and a larger
increase between 1 mM and 20 mM. The latter increase could be
due to the presence of tubulin-decorated Taxol crystals rather than
newly polymerized Taxol-stabilized microtubules. We have cited
just two observations in the literature that could be explained by
the presence of decorated Taxol crystals. However, we hope that
our work may provide an opportunity for others to reevaluate
previous research, resolve additional anomalies, and increase
awareness of Taxol’s strengths and weaknesses as a research tool.
More importantly, should Taxol crystallize in living cells due to
its progressive uptake [22], there could be far-reaching medical
implications. Cytotoxicity in non-dividing cells could result from
the presence of crystals and their sequestration of free tubulin,
rather than by Taxol’s direct interference with the mitotic spindle.
For example, peripheral neuropathy is a debilitating side effect of
Taxol chemotherapy [25]. Neurons, which heavily utilize
microtubule-dependent vesicle transport, may be especially
vulnerable to the presence of Taxol crystals. Our hypothesis is
supported by the discovery that Taxol-treated cultured bovine
aortic endothelial cells are defective in microtubule-dependent
vesicle transport [26]. Again, intracellular crystallization could
provide a mechanism by which transport is impaired.
Neutropenia (characterized by abnormally low neutrophil
counts) is another serious side effect of Taxol chemotherapy
[27]. Neutrophils and platelets are derived from a common
myeloid progenitor, and both circulate in the blood. Electron
micrographs of Taxol-exposed chilled platelets demonstrate a
striking reorganization of microtubules: from the usual circumfer-
ential bands to radiating bundles and ‘‘sheaves of wheat’’-like
structures [28]. Their appearance indicates that Taxol may
crystallize within platelets. It could be interesting to examine the
microtubule configuration in Taxol-treated neutrophils.
Furthermore, in a clinical study, Jiko et al. measured post-
chemotherapy Taxol concentrations in blood serum, revealing a
positive correlation between duration of levels greater than 0.1 mM
and percent decrease in platelet number. Indeed, serum levels
remained above 1 mg/ml (1.2 mM) for approximately four hours
[29]. (Neutrophils are similarly affected by high concentrations of
Taxol [29].) Neutrophils and platelets in Taxol-containing serum are
in some ways analogous to cultured cells in Taxol-containing
medium. Caov-3 ovarian carcinoma cells attain a high intracellular
Taxol concentration (10.7 mM )a f t e rf o u rh o u r si nm e d i u m
containing 30 nM Taxol (and 99.7 mMa f t e r2 4h o u r si n1mM
Taxol) [22]. Thus, it is not unreasonable to think that blood cells may
also attain saturation at clinically applicable concentrations, poten-
tially resulting in neutropenia or other hematological aberrations.
Notably, pharmacological efficacy tended to correlate negatively
with high ‘maximum Taxol concentration’, leading Jiko et al. to
conclude that the dosage in their study may be excessive [29]. This
observation substantiates the well-established mechanism by which
low concentrations of Taxol [30] are sufficient to disrupt cell
division, by stabilizing spindle microtubules. It is also consistent
with our proposed mechanism by which somewhat higher (but still
clinically relevant) concentrations are cytotoxic.
Given that Taxol may crystallize intracellularly, it could be
worth determining whether or how other anti-mitotic drugs
Figure 3. Concentration- and time-dependence of aster formation. (A) Fluorescently labeled Taxol-induced asters (DIC and fluorescent optics)
formed in polymerization solutions stabilized with a concentration gradient of Taxol (left to right): 0.92 mM, 1.0 mM, 10 mM, 20 mM. Asters were not
visible at or below 0.88 mM Taxol. These results are consistent with the low solubility of Taxol in aqueous solution [19]. (B) Taxol crystals, formed in
20 mM Taxol in aqueous buffer. Asters were visualized by DIC microscopy 24 hours after preparation. Compare to the smaller, less-dense aster in Fig. 1
B, which was visualized within 10–60 minutes. Crystals were not a solvent-induced artifact, as no structures were visible in a control solution lacking
Taxol. Bars, 10 mm.
doi:10.1371/journal.pone.0001476.g003
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may be decorated by tubulin. For example, colchicine has been
reported to induce a variety of tubulin-containing arrays that start
out as transitory cortical strands. With prolonged exposure to
colchicine, they transform into ‘‘needle-type bundles, arranged as
different crystalloids and/or macrotubules’’ [31]. Discodermolide
has been reported to increase the microtubule polymer mass and
induce bundling of microtubules [32], and laulimalide enhances
microtubule polymerization, based on turbidity [33]. We hope our
data will provide a steppingstone for others to determine whether
Taxol or similar drugs can crystallize intracellularly, and if so,
under what conditions.
MATERIALS AND METHODS
Microscopy
For micropipetting experiments, a custom-made slide with an
,75 mm
3 chamber was used. For each treatment, a 0.75 ml
sample was pipetted into the chamber under hydrophobic
Halocarbon 400 oil to prevent evaporation. Otherwise, each
0.75 ml sample was sandwiched between a glass slide and a cover
slip, and sealed with silicone grease. The small sample volume
results in flatter droplets, thus improving image clarity. Samples
were visualized at room temperature using a digital-enhanced DIC
microscope (Zeiss Axiovert-100) equipped with a 1.4 NA/63X
Plan-Apochromat objective and a 1.4 NA achromatic-aplanatic
condenser. Images were captured with a CCD digital camera
(MicroMax, Princeton Instruments, Inc.), and processed using
Image Pro Plus (Media Cybernetics) and Adobe Photoshop.
Preparation of Taxol crystals
A stock solution of 1 mM Taxol in Dimethyl sulfoxide (DMSO)
was diluted to 20 mM in BRB 80 buffer (80 mM PIPES, 1 mM
EGTA, 2.1 mM MgCl2, 1 mM GTP, 4% glycerol) [34] in a
microcentrifuge tube. Crystals were removed from the tube and
pipetted under Halocarbon 400 oil into a chamber slide. We
confirmed that the crystals were actually present in larger volumes
of solution (e.g., 100 mL) in the microcentrifuge tubes, and were
not merely forming upon contact with the glass slide. Using both
plastic tips and glass micropipettes, we pipetted crystals from tube
to slide while observing the transfer under the microscope. The
crystals emerged from the tips preformed, and could be seen
immediately at multiple focal planes, not just at the focal plane
adjacent to the glass.
Generation of Taxol-stabilized microtubules
To promote microtubule assembly, 1.14 mg/ml Fluorescein-
tubulin (Cytoskeleton) in BRB 80 buffer was incubated at 37uC
for 20 minutes [34]. Stabilization buffer, consisting of 20 mM
Taxol (Molecular Probes) in BRB 80, was added to the
microtubule polymerization reaction. For concentration-depen-
dence of aster formation, 0.25 mMt o2 0mM Taxol was tested
(Fig. 2).
Crystal micromanipulation and decoration
Micropipettes were pulled from glass capillaries (World Precision
Instruments) using a Flaming/Brown micropipette puller (Sutter
Instruments), and maneuvered with a Burleigh MIS-5000 series
piezoelectric micromanipulator. For decoration of the crystals with
tubulin, 2.5 mg/ml ice-cold fluorescently-labeled tubulin in BRB
80 was back-loaded into a micropipette (tip diameter ,0.1 mm)
using a chilled 2 ml Hamilton syringe. A Narishige microinjector
was used to control tubulin flow. For decoration of the crystals
with an equilibrium mixture of tubulin and microtubules in BRB
80, a micropipette of tip diameter ,0.3 mm was used. The tip
opening was wide enough that intact microtubules could pass
through (as seen in Figure 2 B).
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